These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 832513)
41. Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study. König C; Martens-Lobenhoffer J; Czorlich P; Westphal M; Bode-Böger SM; Kluge S; Grensemann J Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):29. PubMed ID: 37095559 [TBL] [Abstract][Full Text] [Related]
42. Penetration of parenterally administered gentamicin into the cerebrospinal fluid in experimental meningitis. Goitein K; Michel J; Sacks T Chemotherapy; 1975; 21(3-4):181-8. PubMed ID: 1157573 [TBL] [Abstract][Full Text] [Related]
43. [Current aspects of pseudomonas meningitis]. Brückner O; Borner K; Hoffmann HG; Trautmann M; Collmann H Neurochirurgia (Stuttg); 1985 Jan; 28(1):12-6. PubMed ID: 2983254 [TBL] [Abstract][Full Text] [Related]
44. [Bacteriologic and pharmacodynamic basis for treating bacterial meningitis (author's transl)]. Armengaud M Sem Hop; 1982 Feb; 58(5):268-74. PubMed ID: 6277005 [TBL] [Abstract][Full Text] [Related]
45. Aminoglycoside therapy of gram-negative bacillary meningitis. Kaiser AB; McGee ZA N Engl J Med; 1975 Dec; 293(24):1215-20. PubMed ID: 1102982 [TBL] [Abstract][Full Text] [Related]
46. Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group. Ellmén JK; Renkonen OV; Anttila MA; Peltola HO Chemotherapy; 1991; 37(1):1-5. PubMed ID: 1901543 [TBL] [Abstract][Full Text] [Related]
47. Fosfomycin in the treatment of bacterial infections: summary of clinical trials in Japan. Fujii R Chemotherapy; 1977; 23 Suppl 1():234-46. PubMed ID: 832522 [TBL] [Abstract][Full Text] [Related]
48. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis. Humbert G; Leroy A; Nair SR; Cherubin CE J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021 [TBL] [Abstract][Full Text] [Related]
49. Clinical bacteriological evaluation of infantile bacteriuria treated with fosfomycin. Ureta A; Magariños JI; Sousa AS Chemotherapy; 1977; 23 Suppl 1():324-30. PubMed ID: 832532 [TBL] [Abstract][Full Text] [Related]
50. Assessment of antibiotic efficacy in acute bacterial meningitis. Beam TR; Allen JC Clin Pharmacol Ther; 1979 Feb; 25(2):199-203. PubMed ID: 759073 [TBL] [Abstract][Full Text] [Related]
51. [Transferability of cefpirome to cerebrospinal fluid of rabbits with meningitis caused by Staphylococcus aureus]. Haruta T; Okura K; Kuroki S; Kobayashi Y Jpn J Antibiot; 1991 Jan; 44(1):58-61. PubMed ID: 2041148 [TBL] [Abstract][Full Text] [Related]
52. Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis. Barsić B; Himbele J; Beus I; Schönwald S; Marton E; Lisić M Neurol Croat; 1991; 40(2):111-6. PubMed ID: 1883920 [TBL] [Abstract][Full Text] [Related]
53. [Antibacterial activity of the cerebrospinal fluid during antibiotic therapy (50 cases of meningitis)]. Turcu T; Vâţă A; Grigoriu A; Cuciureanu G; Râpeanu E; Mihalache D; Danilă F Rev Med Chir Soc Med Nat Iasi; 1977; 81(2):193-200. PubMed ID: 905675 [No Abstract] [Full Text] [Related]
54. The revival of fosfomycin. Michalopoulos AS; Livaditis IG; Gougoutas V Int J Infect Dis; 2011 Nov; 15(11):e732-9. PubMed ID: 21945848 [TBL] [Abstract][Full Text] [Related]
56. Fosfomycin kinetics after intravenous and oral administration to human volunteers. Goto M; Sugiyama M; Nakajima S; Yamashina H Antimicrob Agents Chemother; 1981 Sep; 20(3):393-7. PubMed ID: 7305325 [TBL] [Abstract][Full Text] [Related]
57. [Transferability of meropenem to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus]. Haruta T; Okura K; Kuroki S; Nikami H; Kobayashi Y Jpn J Antibiot; 1992 Jul; 45(7):809-13. PubMed ID: 1522671 [TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration. Aramayona JJ; Bregante MA; Solans C; Rueda S; Fraile LJ; Garcia MA Vet Res; 1997; 28(6):581-8. PubMed ID: 9428152 [TBL] [Abstract][Full Text] [Related]
59. Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro. Sauermann R; Schwameis R; Fille M; Ligios ML; Zeitlinger M J Antimicrob Chemother; 2009 Oct; 64(4):821-3. PubMed ID: 19622535 [TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics and cerebrospinal fluid penetration of norvancomycin in Chinese adult patients. Li J; He S; Yang Z; Lu C Int J Antimicrob Agents; 2017 May; 49(5):603-608. PubMed ID: 28366660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]